An epidemic in the midst of a pandemic: opioid use disorder and COVID-19 GC Alexander, KB Stoller, RL Haffajee, B Saloner Annals of internal medicine 173 (1), 57-58, 2020 | 386 | 2020 |
Effects of buprenorphine/naloxone in opioid-dependent humans KB Stoller, GE Bigelow, SL Walsh, EC Strain Psychopharmacology 154, 230-242, 2001 | 228 | 2001 |
Assessing the effectiveness of an Internet-based videoconferencing platform for delivering intensified substance abuse counseling VL King, KB Stoller, M Kidorf, K Kindbom, S Hursh, T Brady, RK Brooner Journal of substance abuse treatment 36 (3), 331-338, 2009 | 180 | 2009 |
Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment VL King, RK Brooner, MS Kidorf, KB Stoller, AF Mirsky The Journal of nervous and mental disease 187 (8), 487-495, 1999 | 149 | 1999 |
Assessing traumatic event exposure: comparing the Traumatic Life Events Questionnaire to the Structured Clinical Interview for DSM-IV. JM Peirce, CK Burke, KB Stoller, KJ Neufeld, RK Brooner Psychological Assessment 21 (2), 210, 2009 | 133 | 2009 |
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers EC Strain, K Stoller, SL Walsh, GE Bigelow Psychopharmacology 148, 374-383, 2000 | 128 | 2000 |
Relative bioavailability of different buprenorphine formulations under chronic dosing conditions EC Strain, DE Moody, KB Stoller, SL Walsh, GE Bigelow Drug and alcohol dependence 74 (1), 37-43, 2004 | 114 | 2004 |
Preliminary evidence of good treatment response in antisocial drug abusers RK Brooner, M Kidorf, VL King, K Stoller Drug and Alcohol Dependence 49 (3), 249-260, 1998 | 112 | 1998 |
Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment VL King, MS Kidorf, KB Stoller, RK Brooner Journal of Addictive Diseases 19 (4), 65-83, 2000 | 105 | 2000 |
A multicenter randomized evaluation of methadone medical maintenance VL King, KB Stoller, M Hayes, A Umbricht, M Currens, MS Kidorf, ... Drug and Alcohol Dependence 65 (2), 137-148, 2002 | 84 | 2002 |
Behavioral contingencies improve counseling attendance in an adaptive treatment model RK Brooner, MS Kidorf, VL King, KB Stoller, JM Peirce, GE Bigelow, ... Journal of Substance Abuse Treatment 27 (3), 223-232, 2004 | 78 | 2004 |
Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence RK Brooner, MS Kidorf, VL King, KB Stoller, KJ Neufeld, K Kolodner Drug and Alcohol Dependence 88, S14-S23, 2007 | 76 | 2007 |
Regulatory, Cost and Policy Issues KB Stoller, GE Bigelow Methadone treatment for opioid dependence; Eric C. Strain and Maxine L …, 1999 | 72* | 1999 |
Short-term stability of NEO–PI–R personality trait scores in opioid-dependent outpatients. JA Carter, JH Herbst, KB Stoller, VL King, MS Kidorf, PT Costa Jr, ... Psychology of Addictive Behaviors 15 (3), 255, 2001 | 70 | 2001 |
Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore O Falade-Nwulia, R Irvin, A Merkow, M Sulkowski, A Niculescu, Y Olsen, ... Journal of substance abuse treatment 100, 45-51, 2019 | 68 | 2019 |
Influence of antisocial personality subtypes on drug abuse treatment response VL King, MS Kidorf, KB Stoller, JA Carter, RK Brooner Published abstract in: Drug and Alcohol Dependence 63 (Suppl 1), S81, 2001 | 65 | 2001 |
Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder MR Clark, KB Stoller, RK Brooner The Canadian Journal of Psychiatry 53 (8), 496-508, 2008 | 61 | 2008 |
Involving significant others in the care of opioid-dependent patients receiving methadone M Kidorf, VL King, K Neufeld, KB Stoller, J Peirce, RK Brooner Journal of Substance Abuse Treatment 29 (1), 19-27, 2005 | 60 | 2005 |
Sleep problems reported by patients entering opioid agonist treatment CK Burke, JM Peirce, MS Kidorf, D Neubauer, NM Punjabi, KB Stoller, ... Journal of substance abuse treatment 35 (3), 328-333, 2008 | 56 | 2008 |
Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities EA McClure, SP Acquavita, KE Dunn, KB Stoller, ML Stitzer Journal of substance abuse treatment 46 (2), 194-201, 2014 | 55 | 2014 |